At a glance
ClinicalIndex Comparison RecordN/ACompleted· 69 enrolled
Drug / intervention
Withings Home Blood Pressure Device and Scale +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Wireless Automated Tracking in Cirrhosis Patients at Home (WATCH) Trial: A Randomized Single Blind Trial Testing the Use of Home Monitoring Among Decompensated Cirrhosis Patients
In Brief
A clinical study evaluating Withings Home Blood Pressure Device and Scale and Standard of Care for Cirrhosis, Liver and 2 related conditions. Completed, enrolled 69 participants across 1 site.
Detailed Summary
This is a randomized single-blind feasibility trial to test the utilization of home blood pressure devices to improve the clinical management of decompensated cirrhosis patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCirrhosis, Liver, Portal Hypertension, Ascites Hepatic
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
First PostedJul 2023
Enrollment StartSep 2023
Primary CompletionJul 2024
TodayJul 2026
First PostedJul 3, 2023
Enrollment StartSep 22, 2023
Primary CompletionJul 1, 2024
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 3.0 years ago
Interventions
Withings Home Blood Pressure Device and Scaledevice
The intervention will be whether the data generated from home monitoring devices are shared with the clinical providers. The investigators are not testing the efficacy of these approved devices.
Standard of Careother
Standard of Care